drugset / Trial / NCT07330531
Drug-drug Interaction Study of Rifampin and Anaprazole Sodium
NaSingle-groupOpen-labelTreatment
Summary
A drug-drug interaction study designed to evaluate the drug-drug interaction between rifampin capsules and anaprazole sodium enteric-coated tablets in healthy adult subjects
Timeline
- Start
- 2026-01-04
- Primary completion
- 2026-02-05
- Completion
- 2027-07-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anaprazole | Other / unclassified | 60 mg | Oral |
| Subject | Rifampin | Small molecule | 600 mg | Oral |
Indications
No indication recorded.